These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7117790)

  • 1. The "mirroring" of gallstones: description of a novel silvering method to determine the surface area of an irregular object. In vitro demonstration that multiple gallstones from the same gallbladder dissolve in unsaturated "bile" at the same rate.
    Park YH; Igimi H; Carey MC
    Gastroenterology; 1982 Nov; 83(5):1071-8. PubMed ID: 7117790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution of human cholesterol gallstones in stimulated chenodeoxycholate-rich and ursodeoxycholate-rich biles. An in vitro study of dissolution rates and mechanisms.
    Park YH; Igimi H; Carey MC
    Gastroenterology; 1984 Jul; 87(1):150-8. PubMed ID: 6724258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution of human cholesterol gallstones in vitro with bile salts. A scanning and stereoscanning electron microscopic study.
    Funatsu K; Phillips MJ
    Lab Invest; 1979 Feb; 40(2):166-71. PubMed ID: 431035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of cholesterol gallstones in mice by the oral administration of a fatty acid bile acid conjugate.
    Gilat T; Leikin-Frenkel A; Goldiner I; Halpern Z; Konikoff FM
    Hepatology; 2002 Mar; 35(3):597-600. PubMed ID: 11870372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Innovations in the medical treatment of gallstones and fatty liver: FABACs (Fatty Acid Bile Acid Conjugates)].
    Keizman D; Goldiner I; Leikin-Frenkel A; Konikoff FM
    Harefuah; 2008 Apr; 147(4):344-9, 373, 372. PubMed ID: 18686819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution of cholesterol gallbladder stones with bile salts.
    Leuschner U
    Rev Invest Clin; 1990 Jul; 42 Suppl():174. PubMed ID: 19256161
    [No Abstract]   [Full Text] [Related]  

  • 7. [Internist therapy of cholelithiasis].
    Riemann JF
    Fortschr Med; 1981 May; 99(20):755-60. PubMed ID: 7262755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones.
    Tudyka J; Wechsler JG; Mason R; Maier C
    Am J Gastroenterol; 1994 Aug; 89(8):1206-10. PubMed ID: 8053436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the pathogenesis and treatment of cholesterol gallstones.
    Portincasa P; van de Meeberg P; van Erpecum KJ; Palasciano G; VanBerge-Henegouwen GP
    Scand J Gastroenterol Suppl; 1997; 223():60-9. PubMed ID: 9200309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological changes in gallbladder mucosa in cholelithiasis: correlation with chemical composition of gallstones.
    Baig SJ; Biswas S; Das S; Basu K; Chattopadhyay G
    Trop Gastroenterol; 2002; 23(1):25-7. PubMed ID: 12170916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform.
    Van Erpecum KJ; Van Berge-henegouwen GP; Eckhardt ER; Portincasa P; Van De Heijning BJ; Dallinga-Thie GM; Groen AK
    Hepatology; 1998 Jun; 27(6):1508-16. PubMed ID: 9620320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does pre-treatment with bile acids enhance efficacy of biliary extracorporeal shock wave lithotripsy?
    Wehrmann T; Kleemann N; Caspary WF; Lembcke B
    Z Gastroenterol; 1995 Mar; 33(3):155-8. PubMed ID: 7754647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of hepatolithiasis based on the analysis of components of intrahepatic stones.
    Uchiyama K; Kawai M; Tani M; Terasawa H; Tanimura H; Yamaue H
    Hepatogastroenterology; 2007 Sep; 54(78):1798-804. PubMed ID: 18019721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
    Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
    Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does drug-induced litholysis still have a place in treatment of gallstones?].
    Swobodnik W
    Ther Umsch; 1993 Aug; 50(8):564-9. PubMed ID: 8211857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dissolution of gallstones: reality and prospects].
    Dederer IuM
    Klin Med (Mosk); 1980 May; 58(5):16-21. PubMed ID: 6991803
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.